Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Public ClinicalTrials.gov record NCT03633617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Study identification
- NCT ID
- NCT03633617
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2018
- Primary completion
- Sep 8, 2021
- Completion
- Jun 6, 2022
- Last update posted
- Jun 27, 2023
2018 – 2022
United States locations
- U.S. sites
- 62
- U.S. states
- 27
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneron Study Site | Phoenix | Arizona | 85016 | — |
| Regeneron Study Site | Scottsdale | Arizona | 85259 | — |
| Regeneron Study Site | Little Rock | Arkansas | 72202 | — |
| Regeneron Study Site | La Jolla | California | 92037 | — |
| Regeneron Study Site | Los Angeles | California | 90025 | — |
| Regeneron Study Site | Mountain View | California | 94305 | — |
| Regeneron Study Site | Orange | California | 92868 | — |
| Regeneron Study Site | Rolling Hills Estates | California | 90274 | — |
| Regeneron Study Site | San Diego | California | 92123 | — |
| Regeneron Study Site | Aurora | Colorado | 80045 | — |
| Regeneron Study Site | Aurora | Colorado | 80220 | — |
| Regeneron Study Site | Colorado Springs | Colorado | 80907 | — |
| Regeneron Study Site | Lone Tree | Colorado | 80124 | — |
| Regeneron Study Site | Bristol | Connecticut | 06010 | — |
| Regeneron Study Site | Miami | Florida | 33156 | — |
| Regeneron Study Site | St. Petersburg | Florida | 33701 | — |
| Regeneron Study Site | Boise | Idaho | 83706 | — |
| Regeneron Study Site | Idaho Falls | Idaho | 83404 | — |
| Regeneron Study Site #1 | Chicago | Illinois | 60611 | — |
| Regeneron Study Site #2 | Chicago | Illinois | 60611 | — |
| Regeneron Study Site | Park Ridge | Illinois | 60068 | — |
| Regeneron Study Site | Urbana | Illinois | 61801 | — |
| Regeneron Study Site | Indianapolis | Indiana | 46202 | — |
| Regeneron Study Site | Clive | Iowa | 50325 | — |
| Regeneron Study Site | Iowa City | Iowa | 52242 | — |
| Regeneron Study Site | Topeka | Kansas | 66606 | — |
| Regeneron Study Site | Hagerstown | Maryland | 21742 | — |
| Regeneron Study Site | Boston | Massachusetts | 02111 | — |
| Regeneron Study Site | Worcester | Massachusetts | 01655 | — |
| Regeneron Study Site | Ann Arbor | Michigan | 48109 | — |
| Regeneron Study Site | Chesterfield | Michigan | 48047 | — |
| Regeneron Study Site | Plymouth | Minnesota | 55446 | — |
| Regeneron Study Site | Rochester | Minnesota | 55905 | — |
| Regeneron Study Site | Lincoln | Nebraska | 68505 | — |
| Regeneron Study Site | Omaha | Nebraska | 68130 | — |
| Regeneron Study Site | Great Neck | New York | 11021 | — |
| Regeneron Study Site | Great Neck | New York | 11023 | — |
| Regeneron Study Site | New York | New York | 10016 | — |
| Regeneron Study Site | New York | New York | 10029 | — |
| Regeneron Study Site | New York | New York | 10032 | — |
| Regeneron Study Site | The Bronx | New York | 10461 | — |
| Regeneron Study Site | Chapel Hill | North Carolina | 27599 | — |
| Regeneron Study Site | Cincinnati | Ohio | 45229 | — |
| Regeneron Study Site | Dayton | Ohio | 45415 | — |
| Regeneron Study Site | Dublin | Ohio | 43016 | — |
| Regeneron Study Site | Mentor | Ohio | 44060 | — |
| Regeneron Study Site | Hershey | Pennsylvania | 17033 | — |
| Regeneron Study Site | Philadelphia | Pennsylvania | 19104 | — |
| Regeneron Study Site | Charleston | South Carolina | 29425 | — |
| Regeneron Study Site | Greenville | South Carolina | 29615 | — |
| Regeneron Study Site | Johnson City | Tennessee | 37604 | — |
| Regeneron Study Site | Memphis | Tennessee | 38103 | — |
| Regeneron Study Site | Dallas | Texas | 75207 | — |
| Regeneron Study Site | Fort Worth | Texas | 76104 | — |
| Regeneron Study Site | Garland | Texas | 75044 | — |
| Regeneron Study Site | Houston | Texas | 77030 | — |
| Regeneron Study Site | San Antonio | Texas | 78229 | — |
| Regeneron Study Site | Salt Lake City | Utah | 84132 | — |
| Regeneron Study Site | Charlottesville | Virginia | 22903 | — |
| Regeneron Study Site | Roanoke | Virginia | 24013 | — |
| Regeneron Study Site | Seattle | Washington | 98115 | — |
| Regeneron Study Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03633617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03633617 live on ClinicalTrials.gov.